Penn helped test a promising mRNA cancer vaccine. Here’s what the trial means for the field.
- Posted on September 25, 2026
- By Bing News
- 0 Views
- 1 min read
In brief
Generating AI summary…
Penn helped test a promising mRNA cancer vaccine. Here’s what the trial means for the field.
Denise Fitzsimmons knew that removing the fast-growing lump above her eyebrow in 2024 didn’t eliminate the possibility that her melanoma could return. But a clinical trial at Penn Medicine offered the 63-year-old grandmother from Birdsboro, Pa., hope of a more enduring remission. It tested a novel vaccine, based on Penn’s groundbreaking mRNA research, that trains the patient’s immune system to ...
